Parambir S Dulai

49PUBLICATIONS
108CO-AUTHORS
Innate immunityBusiness information management (incl. records, knowledge and intelligence)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersSocial and community informatics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Jul 15, 2026
Butyrate epigenetically licenses sustained epithelial-T cell crosstalk for intestinal immune tolerance.

|Jun 01, 2026
Advanced therapy treatment patterns in moderate-to-severe ulcerative colitis: a long-term retrospective claims analysis.

|May 28, 2026
A decade of clinical data with vedolizumab: the past, present, and future.

|May 12, 2026
Vedolizumab clinical decision support tool predicts clinically relevant targets in patients with Crohn's disease.

|Apr 28, 2026
Spatial transcriptomics atlas of inflammatory bowel disease to guide implementation in research consortiums and clinical trials.

|Apr 03, 2026
An Enhanced Treatment Algorithm Targeting Mucosal Healing Is Effective and Safe in Older Patients With Crohn's Disease: A Post Hoc Analysis of the REACT2 Trial.

Shane W Goodwin, Sudheer Kumar Vuyyuru, Rocio Sedano

Pageof 9

Frequent Collaborators

14 joint publications

William Sandborn

14 joint publications

Siddharth Singh

14 joint publications

Neeraj Narula

8 joint publications

Brian G Feagan